Competition & Peer Data API & CSV Delivery

Sharps Technology Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Sharps Technology Inc (STSS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
2
Publicly traded peers
Peer Group Market Share
0.02 %
Share of combined sales, Q2 2026
Revenue Growth Y/Y
-
Peers: 13.69 %
Net Margin
-1,141.60 %
Peers: 15.18 %

Key Findings: Sharps Technology Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 2M vs 37,575M combined for tracked competitors (0.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+316.1% annualized vs trailing 12 months), vs accelerating (+3.9%) for its tracked peer group.
  • Profitability: Its -1,141.6% net margin compares with 15.2% for the peer group.
  • Peer revenue share: Sharps Technology Inc accounted for 0.0% of combined revenue among its tracked peer group.
  • Peer differentiation: Revenue per employee of $0.07M compares with $0.39M for the peer group (0.2x).

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

STSS Sales vs. its Competitors, Q2 2026

With a net margin of -1,141.60 %, Sharps Technology Inc reported lower profitability than its competitors (15.18 %).

Sharps Technology Inc generated 0.02 % of the combined sales of its peer group.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/STSS/competitors
https://api.csimarket.com/api/v1/companies/STSS/relationships
https://api.csimarket.com/api/v1/companies/STSS/similar
Programmatic access for models, analytics, and integration workflows.

Sharps Technology Inc vs. its Competitors, Q2 2026

Net margin

Sharps Technology Inc -1,141.6 %
Competitors combined +15.2 %

Revenue run-rate vs trailing 12 months

Sharps Technology Inc +316.1 %
Competitors combined +3.9 %

TTM net margin

Sharps Technology Inc -20,278.9 %
Competitors combined +14.0 %

TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.

Competitor Financial Benchmarking - TTM Commercial

TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Sharps Technology Inc and its 4 competitor groupings. Available under Commercial License.

Entity TTM Revenue Latest Q ×4 Rev Run-rate vs TTM TTM Net Income TTM Net Margin
Sharps Technology Inc $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitors combined $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
High-Confidence Competitors (3) $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitor Financial Benchmarking

TTM revenue, run-rate and net margin benchmarking across Sharps Technology Inc's competitor groups requires a Commercial License.

Sharps Technology Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Sharps Technology Inc No - - Yes
Competitors combined (2) 50% 50% 50% 0%
High-Confidence Competitors (3) 67% 33% 33% 0%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2026

0%market share
  • Sharps Technology Inc0.0%
  • Competitors combined100.0%

Share of combined quarterly revenue of Sharps Technology Inc and its 2 tracked competitors.

See Sharps Technology Inc's full market share breakdown »

STSS Stock Performance relative to its Competitors

STSS Competitors (weighted) Percent change over the selected range

Sharps Technology Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
Competitors Combined
(0 of 2)
33.3%beat U.S.A. 500
High-Confidence
(1 of 3)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Sharps Technology Inc - -
Competitors combined (2) 40.4% 63.2%
High-Confidence Competitors (3) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Sharps Technology Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

STSS Stock Performance relative to High-Confidence Competitors

STSS High-Confidence Competitors (equal-weighted, 3) Percent change over the selected range

5 Best-Performing Tracked Competitors, Trailing 12 Months

#CompetitorTTM Share Price Returnvs U.S.A. 500
1 Medtronic Plc 282.9% Outperformed
2 Retractable Technologies Inc 282.9% Outperformed
Best-Performing Competitor Returns

TTM share price return and U.S.A. 500 outperformance for Sharps Technology Inc's best-performing tracked competitors requires a Commercial License.

Source: CSIMarket API, trailing 12 months.

Publicly Traded Peers of Sharps Technology Inc

Revenue and income for trailing 12 months, in millions of $, except employees
Company Market Cap Revenues Income Employees
Sharps Technology Inc 76.42 1.96 -397.51 29
Medtronic Plc 115,016.45 37,542.00 5,269.00 95,000
Retractable Technologies Inc 20.57 33.49 -3.37 201
SUBTOTAL 115,113.44 37,577.45 4,868.12 95,230

Sources: Sharps Technology Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Sharps Technology Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.

Sharps Technology Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Retractable Technologies, Inc. Named by the company 85% 2022 to 2026 3
Medtronic Minimally Invasive Therapies Named by the company 85% 2022 to 2026 3
B. Braun Named by the company 85% 2022 to 2026 3
Terumo Medical Corp. Named by the company 85% 2022 to 2026 3
Becton Dickinson & Company Named by the company 85% 2022 to 2026 3
Smiths Medical Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Sharps Technology Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Sharps Technology Inc's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
Sharps Technology Inc Digital Assets Treasury 0.00 % Medical Device 0.00 % Consolidated 0.00 %
Medtronic Plc CARDIOVASCULAR 38.34 % Neuroscience Group 28.37 % Medical Surgical 24.10 %
Retractable Technologies Inc Single reportable segment 100.00 % - -

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).

Sharps Technology Inc's Productivity vs Peers Comparison

Revenue and income per employee, trailing 12 months, in $; market cap in millions of $
CompanyMarket CapRevenue / EmployeeIncome / Employee
Sharps Technology Inc 76 67,594 -13,707,252
Medtronic Plc 115,016 395,179 55,463
Retractable Technologies Inc 21 166,605 -16,773
PEERS TOTAL 115,037 394,696 55,311

Sharps Technology Inc's Geographic Revenue Exposure vs Peers

Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.
Company Largest Market 2nd Market 3rd Market
Medtronic Plc United States 49.83 % Total Other Countries, Excluding United States and Ireland 49.77 % Ireland 0.40 %

Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.

Sharps Technology Inc's Position in Industry Market Structure

Market-capitalization share and concentration across all 222 companies in Sharps Technology Inc's industry classification, broader than the peer set above. Market cap in millions of $.

Sharps Technology Inc ranks #0 of 222 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 587, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).

Rank Company Market Cap Industry Share
1 Intuitive Surgical Inc 145,832 13.38 %
2 Medtronic Plc 113,372 10.40 %
3 Stryker Corp 105,405 9.67 %
4 3m Company 88,542 8.12 %
5 Boston Scientific Corporation 1,234 5.2%
6 Becton Dickinson And Company 1,234 5.2%
7 Edwards Lifesciences Corporation 1,234 5.2%
8 Dexcom Inc 1,234 5.2%
9 Resmed Inc 1,234 5.2%
10 Alcon inc 1,234 5.2%
0 Sharps Technology Inc 83 0.00 %
Full Industry Market Structure

Market cap and industry share for the rest of Sharps Technology Inc's industry peers requires a Commercial License.

Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-07-17.

Sharps Technology Inc's Profitability & Cost Structure

Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Medical Equipment & Supplies industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (288 companies).
Metric Company Industry Difference
Gross Margin 120.60 % 53.35 % (avg) +67.2 pp
Operating Margin -19,097.98 % industry median -19,089.6 pp
EBITDA Margin -19,606.39 % -6.82 % (avg) -19,599.6 pp
Capital Intensity (Capex / Revenue) - 5.43 % (avg) -

Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.

Sharps Technology Inc's Valuation vs Competitive Position

Valuation multiples vs the Medical Equipment & Supplies industry average (288 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.
Metric Company Industry Average Difference
P/E - 34.6x -
EV / EBITDA - 19.7x -
P/B 0.4x 4.7x -4.3x
Return on Equity -153.83 % industry aggregate -165.89 %
Return on Invested Capital -72.42 % -2.32 % (avg) -70.10 %

Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.

Sharps Technology Inc's Multi-Year Financial Trajectory

Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.
Metric 2022202320242025
Revenue Growth ----
Operating Margin ----
Return on Invested Capital ---90.04 %-74.67 %
P/E ---0.1x

Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.

Sharps Technology Inc's Competitive Forces (Porter's Five Forces)

Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.
Force Assessment Basis
Competitive Rivalry High Industry HHI of 587 (see Industry Market Structure & Concentration above)
Supplier Power Not covered on this page See Sharps Technology Inc's dedicated suppliers page for concentration and dependency data
Buyer Power Not covered on this page See Sharps Technology Inc's dedicated customers page for concentration and dependency data
Threat of Substitutes - No systematic data source for cross-product substitution exists in this system; not estimated

Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.

Sharps Technology Inc's Industry Attractiveness & Competitive Strength

A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.

High Strength
Medium Strength
Low Strength
High Attractiveness
Invest / Grow
Invest / Grow
Selective
Medium Attractiveness
Invest / Grow
Selective
Harvest
Low Attractiveness
Selective
Harvest
Harvest / Divest Sharps Technology Inc

Sharps Technology Inc falls in the Low attractiveness / Low strength cell: Harvest / Divest.

Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.

Sharps Technology Inc's SWOT

Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.

Strengths

  • Latest-quarter revenue run-rate is accelerating (+316.1% annualized vs trailing 12 months).

Weaknesses

  • Operating margin 19,089.6 points below the industry median.
  • Return on equity 165.9 points below the industry aggregate.
  • Piotroski F-Score of 2 or below, the standard financial-distress signal.

Opportunities

No rule matched.

Threats

No rule matched.

Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.

Sharps Technology Inc's Financial Strength vs Peers Comparison

Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months
CompanyQuick RatioWorking CapitalDebt / EquityAsset Turnover
Sharps Technology Inc 2.22 4.53 0.01 0.01
Medtronic Plc 0.15 2.10 0.57 0.41
Retractable Technologies Inc 0.27 5.88 0.01 0.24

Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.

Sharps Technology Inc's Revenue and Income Growth vs Peers

Quarterly revenue and net income growth, year over year and quarter over quarter
CompanyPeriodRevenue Y/YRevenue Q/QIncome Y/YIncome Q/Q
Sharps Technology Inc Q2 2026-+957.8 %--
Medtronic PlcQ2 2026+13.7 %-0.5 %+41.3 %+17.5 %
Retractable Technologies IncQ2 2026-27.2 %+0.5 %--
PEERS TOTAL+13.7 %-0.5 %+38.8 %+24.8 %

Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.

Sharps Technology Inc's Peers' Costs of Sales and Capital Expenditures

Context for revenue growth: peer costs and capex, year over year and quarter over quarter
CompanyPeriodCosts Y/YCosts Q/QCapex Y/YCapex Q/Q
Sharps Technology Inc Q2 2026+91.3 %+40.3 %-99.2 %-
Medtronic PlcQ2 2026+13.8 %+0.5 %-0.2 %+1,017.8 %
Retractable Technologies IncQ2 2026-29.9 %-12.4 %-91.0 %+378.9 %

Sharps Technology Inc's Returns and Turnover vs Peers

ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover
CompanyROAROIROEReceivables TurnoverInventory Turnover
Sharps Technology Inc ---9.655.68
Medtronic Plc5.71%6.46%10.64%5.802.21
Retractable Technologies Inc---4.141.94

ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).

Sharps Technology Inc's Valuation vs Peers

P/E, price to sales, PEG, price to cash flow and price to book
CompanyP/EPrice / SalesPEGP/CFPrice / Book
Sharps Technology Inc -38.98--0.49
Medtronic Plc263.243.06-275.162.26
Retractable Technologies Inc-0.61--0.28
PEERS AVERAGE23.653.06279.522.25

P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.